Nova Health

Nova Health in Lincoln, Nebraska offers Spravato (esketamine), an FDA-approved treatment for treatment-resistant depression that works differently than traditional antidepressants. Rather than targeting serotonin alone, it acts on the glutamate pathway to help restore neural connections in areas of the brain affected by depression, with many patients experiencing rapid symptom improvement.

Spravato is administered onsite under clinical supervision, followed by a required monitored observation period in a quiet, relaxing space. Sessions are intentionally unhurried, allowing patients to rest while the care team provides support throughout, and transportation home is required since driving is not permitted afterward.

Used alongside oral antidepressants for enhanced benefit, Spravato can be coordinated with a patient's established psychiatric provider. Nova Health emphasizes personalized, evidence-based care focused on safety, monitoring, and long-term outcomes.